Interesting Neuro: Stroke Risks & Treatment
February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.
Adjunctive Opicapone for Parkinson Disease
A phase 3 trial examined the safety and effectiveness of adjunctive opicapone in patients with Parkinson disease treated with levopoda.
Cognitive and Psychiatric Impairment in Parkinson
Can we see changes in the brain that correspond to cognitive difficulties? Research presented at AAN 2016 offers compelling information.
Interesting Neuro: Epilepsy Outcomes & Vitamin D
January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.
Neuro News Roundup: Parkinson & Cognitive Function
Orthostatic hypotension’s effect on cognition in Parkinson disease, testing patients with epilepsy who can drive safely, and carotid web are covered.
Top 10: Neurology Times 2016
From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.
Parkinson Disease: Role for Gut Microbiome
Ground-breaking research suggests that the gut microbiome may play a role in the pathogenesis of Parkinson disease.
Interesting Neuro: Tau Vaccine & Winter Zika Risk
November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.
Interesting Neuro: Alzheimer Updates & PFO Device
November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.
ANA 2016: Selective Neuronal Dysfunction
Data blitz presentations at ANA 2016 featured studies on neuronal dysfunction and degeneration in ALS, Parkinson disease, transverse myelitis, & more.